Andere talen Nevro Corp.

Aandelen

NVRO

US64157F1030

Beurs gesloten - Nyse Andere beurzen 22:00:01 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
11,32 ^USD	-2,58%		-6,21%	-47,40%

15/04	NEVRO CORP. : RBC Capital Markets is Neutraal over het aandeel	ZM
11/04	NEVRO CORP. : Mizuho Securities is Neutraal gestemd over aandeel	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024	17/04
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off	09/04
Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw	28/02
Nevro 2024 Sales Expected Slightly Below Estimates, RBC Says	22/02
Earnings Flash (NVRO) NEVRO Posts Q4 Revenue $116.2M, vs. Street Est of $116M	21/02
Engaged Capital Enters into Agreement with Nevro Corp	21/02
Nevro: Q4 Earnings Snapshot	21/02
Nevro Enters Into Cooperation Agreement With Engaged Capital	21/02
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results	21/02
Nevro Corp. Appoints Kirt P. Karros to Board of Directors and Audit Committee of the Board	21/02
Nevro Corp. Provides Earnings Guidance for the First Quarter and Full Year of 2024	21/02
Nevro Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21/02
Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024	29/01
Top 4 Spinal Injury Stocks for 2024 Watchlist (NRX.V, NVRO, SYK, BSX)	23/01
Top 4 Spinal Injury Stocks for 2024 (NRX.V, NVRO, SYK, BSX)	22/01
Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy	19/01
Sector Update: Health Care Stocks Mixed in Afternoon Trading	09/01
Nevro to Cut 5% of Workforce in Restructuring, Says Preliminary Q4 Revenue Rose 2%	09/01
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results	09/01
Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference	04/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Nevro Corp.

Aandelen

NVRO

US64157F1030

Andere talen

Filters